Cogentix Medical Stock Price, News & Analysis (NASDAQ:CGNT)

$2.91 +0.03 (+1.04 %)
(As of 02/21/2018 08:24 AM ET)
Previous Close$2.88
Today's Range$2.87 - $2.95
52-Week Range$1.55 - $3.34
Volume32,900 shs
Average Volume55,638 shs
Market Capitalization$175.41 million
P/E RatioN/A
Dividend YieldN/A
Beta0.88

About Cogentix Medical (NASDAQ:CGNT)

Cogentix Medical logoCogentix Medical, Inc. is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB). The Company also offers Macroplastique Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence that is primarily due to intrinsic sphincter deficiency. The PrimeSight flexible endoscopes are used in conjunction with the sterile, single-use microbial barrier known as the EndoSheath Protective Barrier. The PrimeSight endoscopy line also includes rigid endoscopes and portable peripherals, such as the video system and stroboscopy unit.

Receive CGNT News and Ratings via Email

Sign-up to receive the latest news and ratings for CGNT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:CGNT
CUSIPN/A
Phone952-426-6140

Debt

Debt-to-Equity RatioN/A
Current Ratio4.64%
Quick Ratio3.82%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$51.85 million
Price / Sales3.42
Cash FlowN/A
Price / CashN/A
Book Value$1.05 per share
Price / Book2.77

Profitability

Trailing EPS($0.41)
Net Income$-22,090,000.00
Net Margins-36.14%
Return on Equity-11.52%
Return on Assets-10.04%

Miscellaneous

Employees177
Outstanding Shares60,910,000

Cogentix Medical (NASDAQ:CGNT) Frequently Asked Questions

What is Cogentix Medical's stock symbol?

Cogentix Medical trades on the NASDAQ under the ticker symbol "CGNT."

How were Cogentix Medical's earnings last quarter?

Cogentix Medical, Inc. (NASDAQ:CGNT) released its quarterly earnings results on Tuesday, November, 3rd. The medical device company reported ($0.06) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.07) by $0.01. The medical device company had revenue of $11.80 million for the quarter, compared to analyst estimates of $11.45 million. Cogentix Medical had a negative return on equity of 11.52% and a negative net margin of 36.14%. View Cogentix Medical's Earnings History.

When will Cogentix Medical make its next earnings announcement?

Cogentix Medical is scheduled to release their next quarterly earnings announcement on Wednesday, March, 7th 2018. View Earnings Estimates for Cogentix Medical.

Where is Cogentix Medical's stock going? Where will Cogentix Medical's stock price be in 2018?

3 analysts have issued 12 month target prices for Cogentix Medical's stock. Their forecasts range from $4.00 to $5.00. On average, they anticipate Cogentix Medical's stock price to reach $4.58 in the next year. View Analyst Ratings for Cogentix Medical.

Who are some of Cogentix Medical's key competitors?

Who are Cogentix Medical's key executives?

Cogentix Medical's management team includes the folowing people:

  • Uri Geiger, Chairman of the Board (Age 49)
  • Darin Hammers, President, Chief Executive Officer, Director
  • Brett A. Reynolds, Chief Financial Officer, Senior Vice President, Principal Financial Officer, Principal Accounting Officer, Secretary (Age 47)
  • Kenneth H. Paulus, Director (Age 57)
  • Cheryl Pegus M.D., Director (Age 52)
  • Lewis C. Pell, Director (Age 71)
  • Kevin H. Roche, Director (Age 66)
  • Nachum Shamir, Director (Age 63)

Who owns Cogentix Medical stock?

Cogentix Medical's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (1.16%), Broadfin Capital LLC (1.10%), Meitav Dash Investments Ltd. (0.99%), Perkins Capital Management Inc. (0.87%), White Pine Capital LLC (0.40%) and Millennium Management LLC (0.17%). Company insiders that own Cogentix Medical stock include Kenneth A Samet and Lewis C Pell. View Institutional Ownership Trends for Cogentix Medical.

Who sold Cogentix Medical stock? Who is selling Cogentix Medical stock?

Cogentix Medical's stock was sold by a variety of institutional investors in the last quarter, including Broadfin Capital LLC and Perkins Capital Management Inc.. View Insider Buying and Selling for Cogentix Medical.

Who bought Cogentix Medical stock? Who is buying Cogentix Medical stock?

Cogentix Medical's stock was bought by a variety of institutional investors in the last quarter, including Meitav Dash Investments Ltd., White Pine Capital LLC, Renaissance Technologies LLC and Millennium Management LLC. Company insiders that have bought Cogentix Medical stock in the last two years include Kenneth A Samet and Lewis C Pell. View Insider Buying and Selling for Cogentix Medical.

How do I buy Cogentix Medical stock?

Shares of Cogentix Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cogentix Medical's stock price today?

One share of Cogentix Medical stock can currently be purchased for approximately $2.91.

How big of a company is Cogentix Medical?

Cogentix Medical has a market capitalization of $175.41 million and generates $51.85 million in revenue each year. The medical device company earns $-22,090,000.00 in net income (profit) each year or ($0.41) on an earnings per share basis. Cogentix Medical employs 177 workers across the globe.

How can I contact Cogentix Medical?

Cogentix Medical's mailing address is 5420 FELTL ROAD, MINNETONKA MN, 55343. The medical device company can be reached via phone at 952-426-6140 or via email at [email protected]


MarketBeat Community Rating for Cogentix Medical (CGNT)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  72 (Vote Outperform)
Underperform Votes:  136 (Vote Underperform)
Total Votes:  208
MarketBeat's community ratings are surveys of what our community members think about Cogentix Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Cogentix Medical (NASDAQ:CGNT) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $4.58$4.58$4.50N/A
Price Target Upside: 60.26% upside60.26% upside55.71% upsideN/A

Cogentix Medical (NASDAQ:CGNT) Consensus Price Target History

Price Target History for Cogentix Medical (NASDAQ:CGNT)

Cogentix Medical (NASDAQ:CGNT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/1/2017AegisInitiated CoverageBuy$4.75HighView Rating Details
11/8/2017Roth CapitalInitiated CoverageBuy -> Buy$4.00N/AView Rating Details
10/6/2017JMP SecuritiesInitiated CoverageMkt Outperform -> Outperform$5.00N/AView Rating Details
(Data available from 2/21/2016 forward)

Earnings

Cogentix Medical (NASDAQ:CGNT) Earnings History and Estimates Chart

Earnings by Quarter for Cogentix Medical (NASDAQ:CGNT)

Cogentix Medical (NASDAQ CGNT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/7/2018N/AView Earnings Details
8/1/2017Q2 2017($0.01)$0.01$13.90 million$14.06 millionViewListenView Earnings Details
5/2/2017Q1 2017($0.01)($0.02)$13.14 million$12.95 millionViewListenView Earnings Details
3/9/2017Q4 2016($0.14)$13.81 million$13.23 millionViewListenView Earnings Details
8/2/2016Q2 2016($0.03)($0.04)$12.21 million$13.01 millionViewN/AView Earnings Details
5/5/2016Q1 2016($0.03)($0.04)$14.41 million$12.21 millionViewN/AView Earnings Details
3/3/2016Q4 2015($0.07)($0.01)$12.97 million$13.64 millionViewN/AView Earnings Details
11/3/2015Q216($0.07)($0.06)$11.45 million$11.80 millionViewN/AView Earnings Details
8/10/2015Q116($0.10)($0.07)$11.34 million$11.20 millionViewListenView Earnings Details
5/14/2015Q415($0.06)($0.15)$49.10 million$7.00 millionViewListenView Earnings Details
2/4/2015Q4 2014($0.15)$4.92 millionViewN/AView Earnings Details
11/5/2014Q3 2014($0.15)$4.11 billionViewN/AView Earnings Details
8/4/2014Q2 2014($0.20)$3.75 millionViewN/AView Earnings Details
4/28/2014Q1 2014($0.20)$4.98 millionViewN/AView Earnings Details
2/3/2014Q3 14($0.03)$4.00 million$4.50 millionViewN/AView Earnings Details
11/11/2013Q3 2013($0.15)$3.97 millionViewN/AView Earnings Details
8/12/2013Q1 2014($0.05)$34.00 million$3.70 millionViewN/AView Earnings Details
4/29/2013Q1 2013($0.20)$4.43 million$4.20 millionViewN/AView Earnings Details
1/28/2013Q4 2012($0.30)($0.15)ViewN/AView Earnings Details
11/5/2012Q213($0.06)($0.07)$3.85 million$3.70 millionViewN/AView Earnings Details
7/26/2012Q2 2012($0.30)($0.30)ViewN/AView Earnings Details
5/15/2012Q1 2012($0.30)($0.35)ViewN/AView Earnings Details
1/31/2012Q4 2011($0.25)($0.27)ViewN/AView Earnings Details
11/7/2011Q3 2011($0.34)ViewN/AView Earnings Details
8/10/2011Q2 2011($0.30)ViewN/AView Earnings Details
6/2/2011Q1 2011($0.45)ViewN/AView Earnings Details
2/9/2011Q4 2010($0.35)ViewN/AView Earnings Details
11/10/2010Q3 2010($0.41)ViewN/AView Earnings Details
8/11/2010Q2 2010($0.35)ViewN/AView Earnings Details
6/2/2010Q1 2010($0.50)ViewN/AView Earnings Details
2/11/2010Q4 2009($0.44)ViewN/AView Earnings Details
11/12/2009Q3 2009($0.45)ViewN/AView Earnings Details
8/14/2009Q2 2009($0.35)ViewN/AView Earnings Details
2/13/2009Q4 2008($0.42)ViewN/AView Earnings Details
11/13/2008Q3 2008($0.35)ViewN/AView Earnings Details
8/14/2008Q2 2008($0.02)ViewN/AView Earnings Details
6/30/2008Q1 2008($0.60)ViewN/AView Earnings Details
2/20/2008Q4 2007($0.30)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Cogentix Medical (NASDAQ:CGNT) Earnings Estimates

Next Year EPS Consensus Estimate: $0.01 EPS

Dividends

Dividend History for Cogentix Medical (NASDAQ:CGNT)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Cogentix Medical (NASDAQ CGNT) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 62.70%
Institutional Ownership Percentage: 13.11%
Insider Trades by Quarter for Cogentix Medical (NASDAQ:CGNT)
Institutional Ownership by Quarter for Cogentix Medical (NASDAQ:CGNT)

Cogentix Medical (NASDAQ CGNT) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/18/2016Kenneth A SametDirectorBuy25,000$2.47$61,750.00125,000View SEC Filing  
6/10/2016Lewis C PellDirectorBuy13,291$0.95$12,626.452,363,300View SEC Filing  
6/1/2016Lewis C PellDirectorBuy894$0.75$670.502,350,009View SEC Filing  
5/31/2016Lewis C PellDirectorBuy500,000$0.79$395,000.001,999,115View SEC Filing  
5/21/2015Kevin H RocheDirectorBuy10,000$1.68$16,800.00View SEC Filing  
5/19/2015Kevin H RocheDirectorBuy10,000$1.60$16,000.00View SEC Filing  
2/20/2015Lewis C PellDirectorBuy20,000$0.51$10,200.00View SEC Filing  
2/19/2015Lewis C PellDirectorBuy10,000$0.48$4,800.00View SEC Filing  
2/18/2015Lewis C PellDirectorBuy30,000$0.45$13,500.00View SEC Filing  
2/13/2015Lewis C PellDirectorBuy20,000$0.47$9,400.00View SEC Filing  
2/11/2015Lewis C PellDirectorBuy35,000$0.46$16,100.00View SEC Filing  
12/23/2014Lewis C PellDirectorBuy80,000$0.85$68,000.00View SEC Filing  
12/22/2014Lewis C PellDirectorBuy40,000$0.86$34,400.00View SEC Filing  
9/23/2014Lewis C PellDirectorBuy5,000$0.99$4,950.00View SEC Filing  
9/19/2014Lewis C PellDirectorBuy3,900$1.00$3,900.00View SEC Filing  
9/17/2014Lewis C PellDirectorBuy5,000$1.02$5,100.00View SEC Filing  
9/16/2014Lewis C PellDirectorBuy5,000$1.07$5,350.00View SEC Filing  
9/12/2014Lewis C PellDirectorBuy23,300$1.04$24,232.00View SEC Filing  
9/8/2014Lewis C PellDirectorBuy30,000$1.04$31,200.00View SEC Filing  
9/3/2014Lewis C PellDirectorBuy30,000$0.98$29,400.00View SEC Filing  
8/27/2014Lewis C PellDirectorBuy10,000$0.92$9,200.00View SEC Filing  
8/26/2014Lewis C PellDirectorBuy30,000$0.93$27,900.00View SEC Filing  
8/19/2014Lewis C PellDirectorBuy22,900$0.98$22,442.00View SEC Filing  
8/13/2014Lewis C PellDirectorBuy43,420$0.91$39,512.20View SEC Filing  
8/8/2014Lewis C PellDirectorBuy27,500$0.95$26,125.00View SEC Filing  
6/6/2014Lewis C PellDirectorBuy10,000$1.13$11,300.00View SEC Filing  
5/21/2014Lewis C PellDirectorBuy5,000$1.09$5,450.00View SEC Filing  
5/16/2014Lewis C PellDirectorBuy14,197$1.02$14,480.94View SEC Filing  
11/18/2013Lewis C PellDirectorBuy6,296$0.91$5,729.36View SEC Filing  
11/15/2013Lewis C PellDirectorBuy20,000$0.90$18,000.00View SEC Filing  
9/18/2013Lewis C PellDirectorBuy16,000$0.91$14,560.00View SEC Filing  
9/13/2013Lewis C PellDirectorBuy5,000$0.92$4,600.00View SEC Filing  
9/10/2013Lewis C PellDirectorBuy5,000$0.92$4,600.00View SEC Filing  
9/9/2013Lewis C PellDirectorBuy4,564$0.95$4,335.80View SEC Filing  
9/6/2013Lewis C PellDirectorBuy5,000$0.97$4,850.00View SEC Filing  
9/3/2013Lewis C PellDirectorBuy11,432$0.97$11,089.04View SEC Filing  
8/29/2013Lewis C PellDirectorBuy1,100$0.98$1,078.00View SEC Filing  
8/27/2013Lewis C PellDirectorBuy11,596$0.97$11,248.12View SEC Filing  
8/26/2013Lewis C PellDirectorBuy14,965$0.97$14,516.05View SEC Filing  
8/19/2013Lewis C PellDirectorBuy25,025$0.94$23,523.50View SEC Filing  
8/15/2013Lewis C PellDirectorBuy15,000$0.92$13,800.00View SEC Filing  
6/28/2013Lewis C PellDirectorBuy28,400$1.00$28,400.00View SEC Filing  
6/27/2013Lewis C PellDirectorBuy45,048$0.99$44,597.52View SEC Filing  
3/15/2013Lewis C PellDirectorBuy30,000$1.14$34,200.00View SEC Filing  
3/12/2013Lewis C PellDirectorBuy45,000$1.10$49,500.00View SEC Filing  
3/7/2013Lewis C PellDirectorBuy60,000$1.09$65,400.00View SEC Filing  
3/4/2013Lewis C PellDirectorBuy20,000$1.06$21,200.00View SEC Filing  
2/26/2013Lewis C PellDirectorBuy66,266$1.01$66,928.66View SEC Filing  
2/21/2013Lewis C PellDirectorBuy25,000$0.99$24,750.00View SEC Filing  
2/19/2013Lewis C PellDirectorBuy5,000$0.99$4,950.00View SEC Filing  
2/7/2013Lewis C PellDirectorBuy9,000$0.99$8,910.00View SEC Filing  
2/5/2013Lewis C PellDirectorBuy25,000$1.01$25,250.00View SEC Filing  
2/1/2013Lewis C PellDirectorBuy10,000$1.09$10,900.00View SEC Filing  
12/27/2012Lewis C PellDirectorBuy10,000$1.07$10,700.00View SEC Filing  
12/17/2012Lewis C PellDirectorBuy21,600$1.10$23,760.00View SEC Filing  
12/13/2012Lewis C PellDirectorBuy18,961$1.10$20,857.10View SEC Filing  
12/10/2012Lewis C PellDirectorBuy6,656$1.10$7,321.60View SEC Filing  
12/3/2012Lewis C PellDirectorBuy8,360$1.10$9,196.00View SEC Filing  
11/30/2012Lewis C PellDirectorBuy45,748$1.10$50,322.80View SEC Filing  
11/27/2012Lewis C PellDirectorBuy3,593$1.10$3,952.30View SEC Filing  
11/23/2012Lewis C PellDirectorBuy39,357$1.09$42,899.13View SEC Filing  
11/19/2012Lewis C PellDirectorBuy57,050$1.08$61,614.00View SEC Filing  
11/14/2012Lewis C PellDirectorBuy100,000$1.15$115,000.00View SEC Filing  
11/12/2012Lewis C PellDirectorBuy24,852$1.17$29,076.84View SEC Filing  
9/6/2012Lewis C PellDirectorBuy10,000$1.37$13,700.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Cogentix Medical (NASDAQ CGNT) News Headlines

Source:
DateHeadline
Comparing Cogentix Medical (CGNT) & Mazor Robotics (MZOR)Comparing Cogentix Medical (CGNT) & Mazor Robotics (MZOR)
www.americanbankingnews.com - February 13 at 10:54 AM
Cogentix Medical (CGNT) Upgraded to "Hold" at Zacks Investment ResearchCogentix Medical (CGNT) Upgraded to "Hold" at Zacks Investment Research
www.americanbankingnews.com - February 12 at 7:18 PM
Cogentix Medical Announces 17% Preliminary Fourth Quarter 2017 Year-Over-Year Revenue GrowthCogentix Medical Announces 17% Preliminary Fourth Quarter 2017 Year-Over-Year Revenue Growth
finance.yahoo.com - February 6 at 9:18 AM
Cogentix Medical (CGNT) Stock Rating Lowered by Zacks Investment ResearchCogentix Medical (CGNT) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - February 1 at 7:14 PM
Zacks: Cogentix Medical, Inc. (CGNT) Given $4.58 Consensus Target Price by AnalystsZacks: Cogentix Medical, Inc. (CGNT) Given $4.58 Consensus Target Price by Analysts
www.americanbankingnews.com - January 17 at 11:40 AM
Cogentix (CGNT) Stock Near 52-Week High: More Room to Run?Cogentix (CGNT) Stock Near 52-Week High: More Room to Run?
www.zacks.com - December 29 at 9:58 AM
ETFs with exposure to Cogentix Medical, Inc. : December 28, 2017ETFs with exposure to Cogentix Medical, Inc. : December 28, 2017
finance.yahoo.com - December 28 at 4:02 PM
Head to Head Analysis: Cogentix Medical (CGNT) and Accuray (ARAY)Head to Head Analysis: Cogentix Medical (CGNT) and Accuray (ARAY)
www.americanbankingnews.com - December 28 at 3:44 PM
Cogentix Medical, Inc. :CGNT-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017Cogentix Medical, Inc. :CGNT-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017
finance.yahoo.com - December 27 at 2:24 PM
Cogentix Medical (CGNT) Downgraded by Zacks Investment Research to "Hold"Cogentix Medical (CGNT) Downgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - December 20 at 5:56 PM
ETFs with exposure to Cogentix Medical, Inc. : December 13, 2017ETFs with exposure to Cogentix Medical, Inc. : December 13, 2017
finance.yahoo.com - December 13 at 5:41 PM
Reviewing Cogentix Medical (CGNT) & Mindray Medical International (MR)Reviewing Cogentix Medical (CGNT) & Mindray Medical International (MR)
www.americanbankingnews.com - December 7 at 5:30 AM
Cogentix Medical Announces Palmetto GBA Extends Medicare Coverage on Urgent® PCCogentix Medical Announces Palmetto GBA Extends Medicare Coverage on Urgent® PC
finance.yahoo.com - December 6 at 9:26 AM
Cogentix Medical (CGNT) in Focus: Stock Moves 6.6% HigherCogentix Medical (CGNT) in Focus: Stock Moves 6.6% Higher
www.zacks.com - December 4 at 9:13 AM
Aegis Initiates Coverage on Cogentix Medical (CGNT)Aegis Initiates Coverage on Cogentix Medical (CGNT)
www.americanbankingnews.com - December 1 at 8:56 AM
Brokerages Anticipate Cogentix Medical, Inc. (CGNT) to Announce $0.00 EPSBrokerages Anticipate Cogentix Medical, Inc. (CGNT) to Announce $0.00 EPS
www.americanbankingnews.com - November 28 at 5:36 AM
Zacks: Cogentix Medical, Inc. (CGNT) Receives Average Recommendation of "Strong Buy" from AnalystsZacks: Cogentix Medical, Inc. (CGNT) Receives Average Recommendation of "Strong Buy" from Analysts
www.americanbankingnews.com - November 21 at 5:23 PM
Cogentix Medical (CGNT) vs. Edwards Lifesciences Corporation (EW) Head to Head SurveyCogentix Medical (CGNT) vs. Edwards Lifesciences Corporation (EW) Head to Head Survey
www.americanbankingnews.com - November 19 at 11:36 AM
Cogentix Medical, Inc. (CGNT) Upgraded to "C" at TheStreetCogentix Medical, Inc. (CGNT) Upgraded to "C" at TheStreet
www.americanbankingnews.com - November 11 at 1:38 PM
Edited Transcript of CGNT earnings conference call or presentation 7-Nov-17 9:30pm GMTEdited Transcript of CGNT earnings conference call or presentation 7-Nov-17 9:30pm GMT
finance.yahoo.com - November 8 at 8:51 PM
Why Cogentix Medical Inc (CGNT) Could Be A BuyWhy Cogentix Medical Inc (CGNT) Could Be A Buy
finance.yahoo.com - November 7 at 8:07 PM
Cogentix Medical Reports Third Quarter Results; Second Highest Quarterly Revenue in Company HistoryCogentix Medical Reports Third Quarter Results; Second Highest Quarterly Revenue in Company History
finance.yahoo.com - November 7 at 8:07 PM
Head to Head Analysis: BIOLASE (BLTI) & Cogentix Medical (CGNT)Head to Head Analysis: BIOLASE (BLTI) & Cogentix Medical (CGNT)
www.americanbankingnews.com - November 6 at 5:44 AM
ETFs with exposure to Cogentix Medical, Inc. : November 2, 2017ETFs with exposure to Cogentix Medical, Inc. : November 2, 2017
finance.yahoo.com - November 2 at 5:55 PM
Cogentix Medical, Inc. (CGNT) to Release Earnings on MondayCogentix Medical, Inc. (CGNT) to Release Earnings on Monday
www.americanbankingnews.com - October 30 at 3:28 AM
Cogentix Medical to Report Third Quarter Results on November 7, 2017Cogentix Medical to Report Third Quarter Results on November 7, 2017
finance.yahoo.com - October 25 at 6:40 PM
ETFs with exposure to Cogentix Medical, Inc. : October 20, 2017ETFs with exposure to Cogentix Medical, Inc. : October 20, 2017
finance.yahoo.com - October 20 at 3:29 PM
ETFs with exposure to Cogentix Medical, Inc. : October 9, 2017ETFs with exposure to Cogentix Medical, Inc. : October 9, 2017
finance.yahoo.com - October 9 at 5:47 PM
Cogentix Medical, Inc. :CGNT-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017Cogentix Medical, Inc. :CGNT-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017
finance.yahoo.com - October 6 at 5:23 PM
Cogentix Medical, Inc. (CGNT) Coverage Initiated by Analysts at JMP SecuritiesCogentix Medical, Inc. (CGNT) Coverage Initiated by Analysts at JMP Securities
www.americanbankingnews.com - October 6 at 9:12 AM
ABIOMED (ABMD) Banks on Impella Platform, Forex a Concern - NasdaqABIOMED (ABMD) Banks on Impella Platform, Forex a Concern - Nasdaq
www.nasdaq.com - September 28 at 10:09 PM
Cogentix Medical Makes $2 Million Investment in Israeli Company Developing Innovative and Novel Device for ... - PR Newswire (press release)Cogentix Medical Makes $2 Million Investment in Israeli Company Developing Innovative and Novel Device for ... - PR Newswire (press release)
www.prnewswire.com - September 28 at 10:09 PM
Cogentix Medical Makes $2 Million Investment in Israeli Company Developing Innovative and Novel Device for Delivery of Drugs to the BladderCogentix Medical Makes $2 Million Investment in Israeli Company Developing Innovative and Novel Device for Delivery of Drugs to the Bladder
finance.yahoo.com - September 28 at 5:07 PM
Allscripts Latest Initiative Eradicates Price AmbiguityAllscripts' Latest Initiative Eradicates Price Ambiguity
finance.yahoo.com - September 15 at 5:31 PM
DaVitas (DVA) Green Initiatives Win a Coveted Golden RewardDaVita's (DVA) Green Initiatives Win a Coveted Golden Reward
finance.yahoo.com - September 15 at 3:59 AM
Critical Analysis: Cogentix Medical (CGNT) and Thermo Fisher Scientific (TMO)Critical Analysis: Cogentix Medical (CGNT) and Thermo Fisher Scientific (TMO)
www.americanbankingnews.com - September 14 at 12:24 PM
Cogentix Medical Announces Cahaba GBA, LLC Extends Coverage for Urgent PC Maintenance TherapyCogentix Medical Announces Cahaba GBA, LLC Extends Coverage for Urgent PC Maintenance Therapy
finance.yahoo.com - September 13 at 6:22 PM
Head to Head Analysis: Cogentix Medical (CGNT) and The CompetitionHead to Head Analysis: Cogentix Medical (CGNT) and The Competition
www.americanbankingnews.com - September 11 at 12:08 AM
Civitas Solutions (CIVI) to Acquire Habilitative ServicesCivitas Solutions (CIVI) to Acquire Habilitative Services
www.zacks.com - August 24 at 5:14 PM
Will Cogentix Medical (CGNT) Continue to Surge Higher?Will Cogentix Medical (CGNT) Continue to Surge Higher?
www.nasdaq.com - August 9 at 5:20 PM
Edited Transcript of CGNT earnings conference call or presentation 1-Aug-17 8:30pm GMTEdited Transcript of CGNT earnings conference call or presentation 1-Aug-17 8:30pm GMT
finance.yahoo.com - August 2 at 5:53 PM
Cogentix Medical, Inc. (CGNT) Posts Quarterly  Earnings Results, Beats Expectations By $0.02 EPSCogentix Medical, Inc. (CGNT) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS
www.americanbankingnews.com - August 2 at 12:08 PM
Cogentix Medical Reports Strong Second Quarter Operating Results with 11% Urology Revenue Growth; Recently Executed Business Development Transactions Expected to Add Approximately 10 Points of Urology Revenue Growth in 2018Cogentix Medical Reports Strong Second Quarter Operating Results with 11% Urology Revenue Growth; Recently Executed Business Development Transactions Expected to Add Approximately 10 Points of Urology Revenue Growth in 2018
finance.yahoo.com - August 1 at 5:49 PM
Corporate News Blog - Cogentix Medical Acquires Genesis Medical to Further Increase Urology Products Revenue Growth RateCorporate News Blog - Cogentix Medical Acquires Genesis Medical to Further Increase Urology Products Revenue Growth Rate
finance.yahoo.com - July 28 at 6:47 PM
Perkins Capital Management Inc Buys AmerisourceBergen Corp, Pentair PLC, Zagg Inc, Sells ...Perkins Capital Management Inc Buys AmerisourceBergen Corp, Pentair PLC, Zagg Inc, Sells ...
www.nasdaq.com - July 27 at 4:35 PM
Cogentix Medical (CGNT) Acquires Genesis MedicalCogentix Medical (CGNT) Acquires Genesis Medical
www.streetinsider.com - July 27 at 3:40 AM
Cogentix Medical Acquires Genesis Medical; Transaction to Further Increase Urology Products Revenue Growth RateCogentix Medical Acquires Genesis Medical; Transaction to Further Increase Urology Products Revenue Growth Rate
finance.yahoo.com - July 26 at 5:44 PM
Cogentix Medical, Inc. (CGNT) Scheduled to Post Quarterly Earnings on TuesdayCogentix Medical, Inc. (CGNT) Scheduled to Post Quarterly Earnings on Tuesday
www.americanbankingnews.com - July 25 at 7:20 AM
Cogentix Medical to Report Second Quarter Results on August 1, 2017Cogentix Medical to Report Second Quarter Results on August 1, 2017
finance.yahoo.com - July 20 at 6:57 PM
Cogentix Medical Signs Agreement to Launch Endo-Urology Product Line in US; Launch to Further Increase Urology Products Growth Rate During 2018Cogentix Medical Signs Agreement to Launch Endo-Urology Product Line in US; Launch to Further Increase Urology Products Growth Rate During 2018
finance.yahoo.com - July 18 at 6:40 PM

SEC Filings

Cogentix Medical (NASDAQ:CGNT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Cogentix Medical (NASDAQ:CGNT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Cogentix Medical (NASDAQ CGNT) Stock Chart for Wednesday, February, 21, 2018

Loading chart…

This page was last updated on 2/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.